HELPING THE OTHERS REALIZE THE ADVANTAGES OF LENMELDY

The FDA assessed the security and effectiveness of atidarsagene autotemcel determined by details from 37 children who obtained atidarsagene autotemcel in two single-arm, open-label clinical trials and in an expanded access plan.[7] Young children who gained cure with atidarsagene autotemcel ended up compared to untreated kids (organic background).[